Clinical Trial Update: Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23 [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and immunogenicity of combined immunization with a COVID-19 inactivated vaccine alongside quadrivalent influenza vaccine (QIV) a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• COVID-19 inactivated vaccine
• Pneumococcal polysaccharide vaccine (PPV23)
• Quadrivalent influenza vaccine (QIV)

Snippet

Sponsor: Centers for Disease Control and Prevention, China | Conditions: Safety, Immunogenicity, Vaccine | Phase 4 | Status: UNKNOWN